Infectious Diseases
Conference Coverage
Novel antifungal had favorable safety, efficacy profile for onychomycosis in phase IIB study
ORLANDO – A new antifungal is set to move to phase III studies after meeting study endpoints with significant separation from controls, in...
From the Journals
Hepatitis Outlook: Late February 2017
Why does HCV continue to be one of leading blood-borne infections in Europe? Read about this and other notable hepatitis news in our regular...
From the Journals
Shingles vaccine deemed effective in people with autoimmune disease
Older adults with an autoimmune disease benefited for about 5 years before the vaccine’s effectiveness began to wane.
Conference Coverage
Dexmedetomidine improves sedation in sepsis
Use of dexmedetomidine improved sedation among ventilated patients with sepsis, but did not significantly cut mortality rates or increase...
From the Journals
HIV vaccine could prevent 30 million cases by 2035
Global cases of HIV from 2015 to 2035 could be reduced by more than 50% if a moderately effective HIV vaccine is introduced by 2020.
News from the FDA/CDC
U.S. influenza activity remains steady
The proportion of U.S. outpatient visits for influenza-like illness stayed at 3.7% for a second consecutive week after declining the previous 3...
Conference Coverage
Survey finds chronic rhinosinusitis common, burdensome
ATLANTA – Results from a large cross-sectional survey of adults who meet diagnostic symptom criteria for chronic rhinosinusitis reveal that most...
From the Journals
HIV research update: Late February 2017
Greater attention is needed to build a more comprehensive understanding of the rural HIV epidemic in the United States and Canada, according to a...
From the Journals
HCV ‘cure’ within the VA appears likely
The VA has removed barriers to treatment and allocated funds for the costly but effective drugs to treat HCV.
Conference Coverage
How to ‘de-label’ penicillin allergies in the hospital
ATLANTA – Many patients with alleged penicillin allergy don’t have it.
News from the FDA/CDC
U.S. flu activity continues to decline
The 2016-2017 U.S. influenza season appears to have peaked, as activity measures dropped for the third consecutive week.